The Health Marketing Daily — June 30, 2026

The Health Marketing Daily | L'integratore Plastikdren promette di "eliminare le | Ozempic and Mounjaro linked to a | Wellness Briefing: Inside Classpass' category expansion

The Health Marketing Daily — July 25, 2026 In this episode: • Italy's advertising self-regulator has ordered a supplement brand to halt claims that its product can 'eliminate microplastics' from the body — a direct warning shot for any brand tempted to exploit the microplastics anxiety trend. • A large new study linking GLP-1 drugs to increased hair loss risk opens a genuine white space for supplement brands in the hair, skin, and nails category to position alongside — not against — weight management drug users. • ClassPass is deliberately repositioning from fitness booking app to full-spectrum wellness platform — a structural shift that signals where the wellness consumer is headed and which distribution channels supplement and wellness brands should be watching. • A new German academic study is formally testing a weight-neutral approach to obesity care — a challenge to the dominant weight-loss narrative that has major implications for how wellness brands frame their messaging to consumers living with obesity. Hosted by Marco & Klara. New episode every weekday. Tags: health marketing, nutraceuticals, supplements, functional nutrition, wellness, clinical evidence, regulatory, consumer health

The Health Marketing Daily | STAT+: In win for RFK Jr., | Conad Nord Ovest Opens First Integrated | This Strange 'Poop Transplant' Study Could

The Health Marketing Daily — July 24, 2026 In this episode: • A pivotal FDA advisory vote to allow compounding pharmacies to produce BPC-157 and KPV peptides marks a regulatory turning point for the grey-market wellness peptide category. • Italy's Conad has opened a dedicated wellness retail concept store in Florence, signalling that mainstream European grocery is moving aggressively into specialist health and wellbeing territory. • New research connecting faecal microbiome transplants to neuroplasticity and healthy ageing is giving the gut-brain-longevity axis a major scientific boost with direct implications for probiotic and postbiotic brand positioning. • The Nue Co.'s dramatic pivot from supplements to fragrance — with fragrance now set to represent 85% of revenue — is a striking case study in how wellness brands reposition when core categories soften. Hosted by Marco & Klara. New episode every weekday. Tags: health marketing, nutraceuticals, supplements, functional nutrition, wellness, clinical evidence, regulatory, consumer health

The Health Marketing Daily | Semaglutid-Tablette in Deutschland voraussichtlich im 3. | La salud redefine las decisiones de | Big Food contro la salute pubblica:

The Health Marketing Daily — July 23, 2026 In this episode: • Novo Nordisk's oral semaglutide tablet is expected to launch in Germany in Q3 2026 — a commercial milestone that will sharply accelerate GLP-1 accessibility and reshape the weight management supplement market across Europe. • Spanish retail data shows health is now the primary driver of supermarket purchase decisions, with consumers actively scanning for functional ingredients — a direct brief for brands competing on health positioning at shelf. • An international investigation coordinated by Lighthouse Reports has revealed that Big Food companies have filed 239 legal cases globally to block health labelling, taxes, and new food regulations — a story with direct implications for how the regulatory environment for health claims and functional food marketing will evolve in Europe. • Refrigerated protein bar brand Perfect Snacks is doubling down on format innovation and ecommerce as mainstream momentum builds — a channel and product strategy story that has direct read-across for European sports nutrition and functional snack brands. Hosted by Marco & Klara. New episode every weekday. Tags: health marketing, nutraceuticals, supplements, functional nutrition, wellness, clinical evidence, regulatory, consumer health

The Health Marketing Daily | This food compound may help vaccines | Ozempic-maker accuses rival of false advertising | Welch's Fruit Snacks targets Gen Z

The Health Marketing Daily — July 22, 2026 In this episode: • New research shows a naturally occurring food compound found in wheat germ, mushrooms, and aged cheese could boost vaccine efficacy in older adults — a direct opportunity for nutraceutical and functional food brands targeting the longevity and immune health market. • Novo Nordisk's lawsuit against Eli Lilly over allegedly misleading GLP-1 drug ads marks a significant escalation in the weight management drug wars — and signals how fiercely contested the marketing narrative around these drugs is becoming. • Welch's Fruit Snacks is launching probiotic-fortified Yogofruits to court Gen Z, signalling that mainstream confectionery brands are aggressively pivoting into functional health territory previously owned by specialist wellness brands. • New European research from EIT Food confirms that consumers respond to personal health and taste benefits — not sustainability or agricultural messaging — a direct challenge to how many functional food and wellness brands are currently framing their products. Hosted by Marco & Klara. New episode every weekday. Tags: health marketing, nutraceuticals, supplements, functional nutrition, wellness, clinical evidence, regulatory, consumer health

The Health Marketing Daily | Sam's Club takes Manhattan for wellness | Aktualisierte Handlungsempfehlungen für Kinderwunsch und Schwangerschaft | Microbioma e medicina anticipatoria: come le

The Health Marketing Daily — July 21, 2026 In this episode: • Sam's Club's first-ever creator-led wellness event signals that warehouse retail is now competing seriously for health and wellness mindshare through experiential marketing. • Germany's leading nutrition network has updated its official recommendations for supplementation and diet during pre-conception and pregnancy, creating an immediate reference point for brands in the maternal health category. • A major Italian mainstream business publication is running a feature-length piece on the microbiome as a lifelong health ecosystem, bringing gut health science firmly into the consumer mainstream. • New evidence that GLP-1 drugs reduce alcohol cravings is opening a conversation about their broader appetite-suppression effects — and what that means for functional beverage and supplement brands positioning around craving control. Hosted by Marco & Klara. New episode every weekday. Tags: health marketing, nutraceuticals, supplements, functional nutrition, wellness, clinical evidence, regulatory, consumer health